FibroGen Statistics

Total Valuation

FibroGen has a market cap or net worth of $29.06 million. The enterprise value is $89.30 million.

Market Cap	29.06M
Enterprise Value	89.30M

Important Dates

The last earnings date was Monday, May 12, 2025, after market close.

Earnings Date	May 12, 2025
Ex-Dividend Date	n/a

Share Statistics

FibroGen has 101.04 million shares outstanding. The number of shares has increased by 2.20% in one year.

Current Share Class	101.04M
Shares Outstanding	101.04M
Shares Change (YoY)	+2.20%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	1.50%
Owned by Institutions (%)	24.51%
Float	91.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.57
Forward PS	0.21
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	12.76
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.02

Current Ratio	2.02
Quick Ratio	0.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.48

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-22.73%
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-105.17%
Revenue Per Employee	$31,093
Profits Per Employee	-$44,476
Employee Count	225
Asset Turnover	0.03
Inventory Turnover	4.12

Taxes

Income Tax	-274,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -75.42% in the last 52 weeks. The beta is 0.87, so FibroGen's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-75.42%
50-Day Moving Average	0.31
200-Day Moving Average	0.39
Relative Strength Index (RSI)	39.52
Average Volume (20 Days)	727,691

Short Selling Information

The latest short interest is 4.68 million, so 4.63% of the outstanding shares have been sold short.

Short Interest	4.68M
Short Previous Month	3.76M
Short % of Shares Out	4.63%
Short % of Float	5.14%
Short Ratio (days to cover)	7.65

Income Statement

In the last 12 months, FibroGen had revenue of $7.00 million and -$10.01 million in losses. Loss per share was -$0.10.

Revenue	7.00M
Gross Profit	-55.85M
Operating Income	-96.57M
Pretax Income	-168.39M
Net Income	-10.01M
EBITDA	-94.38M
EBIT	-96.57M
Loss Per Share	-$0.10

Full Income Statement

Balance Sheet

The company has $33.61 million in cash and $91.22 million in debt, giving a net cash position of -$57.61 million or -$0.57 per share.

Cash & Cash Equivalents	33.61M
Total Debt	91.22M
Net Cash	-57.61M
Net Cash Per Share	-$0.57
Equity (Book Value)	-174.93M
Book Value Per Share	-2.15
Working Capital	75.14M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.99 million and capital expenditures -$253,000, giving a free cash flow of -$76.25 million.

Operating Cash Flow	-75.99M
Capital Expenditures	-253,000
Free Cash Flow	-76.25M
FCF Per Share	-$0.75

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,380.42%
Pretax Margin	-1,730.87%
Profit Margin	-143.04%
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FibroGen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.20%
Shareholder Yield	-2.20%
Earnings Yield	-31.58%
FCF Yield	-240.62%

Analyst Forecast

The average price target for FibroGen is $10.00, which is 3,377.05% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$10.00
Price Target Difference	3,377.05%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	74.68%
EPS Growth Forecast (5Y)	-1.44%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FibroGen has an Altman Z-Score of -17.19 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-17.19
Piotroski F-Score	1